@article{shamoo.ajb,
  title={Strategies to Minimize Risks and Exploitation in Phase One Trials on Healthy Subjects},
  author={Shamoo, Adil E and Resnik, David B},
  journal={The American Journal of Bioethics},
  volume={6},
  number={3},
  pages={W1--W13},
  year={2006},
  publisher={Taylor \& Francis}
}

@misc{hhs.informedconsent,
  title = {{Informed Consent FAQs} (\url{http://www.hhs.gov/ohrp/regulations-and-policy/guidance/faq/informed-consent/index.html})},
  year = {2016; accessed 19 Aug, 2016}
}

@article{penel.bmcmrm,
  title={{What does a modified-Fibonacci dose-escalation actually correspond to?}},
  author={Penel, Nicolas and Kramar, Andrew},
  journal={BMC Medical Research Methodology},
  volume={12},
  number={1},
  pages={1},
  year={2012},
  publisher={BioMed Central}
}

@article{storer.biometrics,
  title={Design and analysis of phase I clinical trials},
  author={Storer, Barry E},
  journal={Biometrics},
  pages={925--937},
  year={1989},
  publisher={JSTOR}
}

@article{garrett.clinicaltrials,
  title={The continual reassessment method for dose-finding studies: a tutorial},
  author={Garrett-Mayer, Elizabeth},
  journal={Clinical Trials},
  volume={3},
  number={1},
  pages={57--71},
  year={2006},
  publisher={SAGE Publications}
}

@article{oquigley.biometrics,
  title={Continual reassessment method: a practical design for phase 1 clinical trials in cancer},
  author={O'Quigley, John and Pepe, Margaret and Fisher, Lloyd},
  journal={Biometrics},
  pages={33--48},
  year={1990},
  publisher={JSTOR}
}

@article{storer.sim,
  title={An evaluation of phase {I} clinical trial designs in the continuous dose--response setting},
  author={Storer, Barry E},
  journal={Statistics in medicine},
  volume={20},
  number={16},
  pages={2399--2408},
  year={2001}
}

@article{thall.biometrics,
  title={Practical Bayesian guidelines for phase IIB clinical trials},
  author={Thall, Peter F and Simon, Richard},
  journal={Biometrics},
  pages={337--349},
volume = 50,
  year={1994}
}

@article{hay.naturebiotech,
	title = {Clinical development success rates for investigational drugs},
	author = {Michael Hay and David W Thomas and John L Craighead and Celia Economides and Jesse Rosenthal},
	journal = {Nature Biotechnology},
	volume = {32},
	number = 1,
	pages = {40-51},
	year = 2014
}

@article{wieand.jco,
  title={Randomized phase {II} trials: what does randomization gain?},
  author={Wieand, H. Samuel},
  journal={Journal of Clinical Oncology},
  volume={23},
  number={9},
  pages={1794--1795},
  year={2005}
}

@article{samet.addiction,
  title={Linking alcohol-and drug-dependent adults to primary medical care: a randomized controlled trial of a multi-disciplinary health intervention in a detoxification unit},
  author={Samet, Jeffrey H and Larson, Mary Jo and Horton, Nicholas J and Doyle, Kathleen and Winter, Michael and Saitz, Richard},
  journal={Addiction},
  volume={98},
  number={4},
  pages={509--516},
  year={2003}
}

@article{dahlberg.jnci,
  title={Evaluation of Statistical Designs in Phase {I} Expansion Cohorts: The Dana-Farber/Harvard Cancer Center Experience},
  author={Dahlberg, Suzanne E and Shapiro, Geoffrey I and Clark, Jeffrey W and Johnson, Bruce E},
  journal={Journal of the National Cancer Institute},
  volume={106},
  number={7},
  pages={dju163},
  year={2014}
}

@article{jain.ccr,
  title={Phase {I} oncology studies: evidence that in the era of targeted therapies patients on lower doses do not fare worse},
  author={Jain, Rajul K and Lee, J Jack and Hong, David and Markman, Maurie and Gong, Jing and Naing, Aung and Wheler, Jennifer and Kurzrock, Razelle},
  journal={Clinical Cancer Research},
  volume={16},
  number={4},
  pages={1289--1297},
  year={2010}
}

@article{rubinstein.ccr,
  title={Randomized phase II designs},
  author={Rubinstein, Larry and Crowley, John and Ivy, Percy and LeBlanc, Michael and Sargent, Dan},
  journal={Clinical Cancer Research},
  volume={15},
  number={6},
  pages={1883--1890},
  year={2009}
}

@book{yin2012,
  title={Clinical Trial Design: Bayesian and Frequentist Adaptive Methods},
  author={Yin, Guosheng},
  volume={876},
  year={2012},
  publisher={John Wiley \& Sons}
}

@article{freidlin.jco,
  title={Randomized phase II trial designs with biomarkers},
  author={Freidlin, Boris and McShane, Lisa M and Polley, Mei-Yin C and Korn, Edward L},
  journal={Journal of Clinical Oncology},
  volume={30},
  number={26},
  pages={3304--3309},
  year={2012},
  publisher={American Society of Clinical Oncology}
}

@book{cook2007,
  title={Introduction to statistical methods for clinical trials},
  author={Cook, Thomas D and DeMets, David L},
  year={2007},
  publisher={CRC Press}
}

@incollection{sampsize.encycbiostat,
	editor = {Redmond, Carol and Colton, Theodore}, 
	author = {Lakatos, E},
	title = {Sample Size Determination},
	booktitle = {Biostatistics in Clinical Trials},
	year = {2001}, 
	  publisher={John Wiley \& Sons},
	pages = {399-406}
}

@book{piantadosi2005,
  title={Clinical trials: a methodologic perspective},
  author={Piantadosi, Steven},
  year={2005},
  publisher={John Wiley \& Sons}
}

@book{friedman2010,
  title={Fundamentals of clinical trials},
  author={Friedman, Lawrence M and Furberg, Curt and DeMets, David L},
  edition={4th},
  year={2010},
  publisher={Springer}
}

@article{prentice.sim,
  title={Surrogate endpoints in clinical trials: definition and operational criteria},
  author={Prentice, Ross L},
  journal={Statistics in medicine},
  volume={8},
  number={4},
  pages={431--440},
  year={1989}
}

@article{besarab.nejm2,
  title={The normal hematocrit study—follow-up},
  author={Besarab, Anatole and Goodkin, David A and Nissenson, Allen R},
  journal={New England Journal of Medicine},
  volume={358},
  number={4},
  pages={433--434},
  year={2008},
  publisher={Mass Medical Soc}
}

@article{coyne.ki,
  title={The health-related quality of life was not improved by targeting higher hemoglobin in the Normal Hematocrit Trial},
  author={Coyne, Daniel W},
  journal={Kidney international},
  volume={82},
  number={2},
  pages={235--241},
  year={2012},
  publisher={Nature Publishing Group}
}

@article{nocturnal.aim,
  title={Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial},
  author={{Nocturnal Oxygen Therapy Trial Group} and others},
  journal={Ann Intern Med},
  volume={93},
  number={3},
  pages={391--398},
  year={1980}
}

@article{efron.biometrika,
  title={Forcing a sequential experiment to be balanced},
  author={Efron, Bradley},
  journal={Biometrika},
  volume={58},
  number={3},
  pages={403--417},
  year={1971},
  publisher={Biometrika Trust}
}

@article{wei.jasa,
  title={An application of an urn model to the design of sequential controlled clinical trials},
  author={Wei, LJ},
  journal={Journal of the American Statistical Association},
  volume={73},
  number={363},
  pages={559--563},
  year={1978},
  publisher={Taylor \& Francis Group}
}

@article{wei.aos,
  title={The adaptive biased coin design for sequential experiments},
  author={Wei, LJ},
  journal={The Annals of Statistics},
  pages={92--100},
  year={1978},
  publisher={JSTOR}
}

@article{robinson.isr,
  title={Some surprising results about covariate adjustment in logistic regression models},
  author={Robinson, Laurence D and Jewell, Nicholas P},
  journal={International Statistical Review/Revue Internationale de Statistique},
  pages={227--240},
  year={1991},
  publisher={JSTOR}
}

@article{chastang.sim,
  title={A quantitative study of the bias in estimating the treatment effect caused by omitting a balanced covariate in survival models},
  author={Chastang, Claude and Byar, David and Piantadosi, Steven},
  journal={Statistics in Medicine},
  volume={7},
  number={12},
  pages={1243--1255},
  year={1988},
  publisher={Wiley Online Library}
}


@incollection{covadjust.encycbiostat,
	editor = {Redmond, Carol and Colton, Theodore}, 
	author = {Altman, Douglas G.},
	title = {Covariate Imbalance, Adjustment for},
	booktitle = {Biostatistics in Clinical Trials},
	year = {2001}, 
	  publisher={John Wiley \& Sons},
	pages = {122--126}
}


@book{jennison.groupsequential,
  title={Group sequential methods with applications to clinical trials},
  author={Jennison, Christopher and Turnbull, Bruce W},
  year={2010},
  publisher={CRC Press}
}

@article{obrien.biometrics,
  title={A multiple testing procedure for clinical trials},
  author={O'Brien, Peter C and Fleming, Thomas R},
  journal={Biometrics},
  pages={549--556},
  year={1979},
  publisher={JSTOR}
}

@article{pocock.biometrika,
  title={Group sequential methods in the design and analysis of clinical trials},
  author={Pocock, Stuart J},
  journal={Biometrika},
  volume={64},
  number={2},
  pages={191--199},
  year={1977},
  publisher={Biometrika Trust}
}

@article{armitage.jrssa,
  title={Repeated significance tests on accumulating data},
  author={Armitage, Peter and McPherson, CK and Rowe, BC},
  journal={Journal of the Royal Statistical Society. Series A (General)},
  pages={235--244},
  year={1969},
  publisher={JSTOR}
}

@article{asrani.ajt,
  title={De Novo Sirolimus and Reduced-Dose Tacrolimus Versus Standard-Dose Tacrolimus After Liver Transplantation: The 2000--2003 Phase II Prospective Randomized Trial},
  author={Asrani, SK and Wiesner, RH and Trotter, JF and Klintmalm, G and Katz, E and Maller, E and Roberts, J and Kneteman, N and Teperman, L and Fung, JJ and others},
  journal={American Journal of Transplantation},
  volume={14},
  number={2},
  pages={356--366},
  year={2014},
  publisher={Wiley Online Library}
}

@article{grode.vaccine,
  title={Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial},
  author={Grode, Leander and Ganoza, Christian A and Brohm, Christiane and Weiner, January and Eisele, Bernd and Kaufmann, Stefan HE},
  journal={Vaccine},
  volume={31},
  number={9},
  pages={1340--1348},
  year={2013},
  publisher={Elsevier}
}

@article{rasmussen.lancet,
  title={Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial},
  author={Rasmussen, Thomas A and Tolstrup, Martin and Brinkmann, Christel R and Olesen, Rikke and Erikstrup, Christian and Solomon, Ajantha and Winckelmann, Anni and Palmer, Sarah and Dinarello, Charles and Buzon, Maria and others},
  journal={The Lancet HIV},
  volume={1},
  number={1},
  pages={e13--e21},
  year={2014},
  publisher={Elsevier}
}

@article{simon.biometrics,
  title={Adaptive treatment assignment methods and clinical trials},
  author={Simon, Richard},
  journal={Biometrics},
  pages={743--749},
  year={1977},
  publisher={JSTOR}
}

@article{cheung.biometrics,
  title={Sequential designs for phase I clinical trials with late-onset toxicities},
  author={Cheung, Ying Kuen and Chappell, Rick},
  journal={Biometrics},
  volume={56},
  number={4},
  pages={1177--1182},
  year={2000},
  publisher={Wiley Online Library}
}

@article{babb.sim,
  title={Cancer phase I clinical trials: efficient dose escalation with overdose control},
  author={Babb, James and Rogatko, Andr{\'e} and Zacks, Shelemyahu},
  journal={Statistics in medicine},
  volume={17},
  number={10},
  pages={1103--1120},
  year={1998}
}


@article{sacks.circulation,
  title={Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy in Type 2 Diabetes Mellitus A Global Case--Control Study in 13 Countries},
  author={Sacks, Frank M and Hermans, Michel P and Fioretto, Paola and Valensi, Paul and Davis, Timothy and Horton, Edward and Wanner, Christoph and Al-Rubeaan, Khalid and Aronson, Ronnie and Barzon, Isabella and others},
  journal={Circulation},
  volume={129},
  number={9},
  pages={999--1008},
  year={2014}
  }

@article{zhang.sim,
  title={An adaptive dose-finding design incorporating both toxicity and efficacy},
  author={Zhang, Wei and Sargent, Daniel J and Mandrekar, Sumithra},
  journal={Statistics in medicine},
  volume={25},
  number={14},
  pages={2365--2383},
  year={2006},
  publisher={Wiley Online Library}
}


@article{thall.biometrics,
  title={Practical Bayesian guidelines for phase IIB clinical trials},
  author={Thall, Peter F and Simon, Richard},
  journal={Biometrics},
  pages={337--349},
volume = 50,
  year={1994}
}


@article{freidlin.jco,
  title={Randomized phase II trial designs with biomarkers},
  author={Freidlin, Boris and McShane, Lisa M and Polley, Mei-Yin C and Korn, Edward L},
  journal={Journal of Clinical Oncology},
  volume={30},
  number={26},
  pages={3304--3309},
  year={2012},
  publisher={American Society of Clinical Oncology}
}

@article{gehan.jcd,
  title={The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent},
  author={Gehan, Edmund A},
  journal={Journal of chronic diseases},
  volume={13},
  number={4},
  pages={346--353},
  year={1961},
  publisher={Elsevier}
}

@article{simon.cct,
  title={Optimal two-stage designs for phase II clinical trials},
  author={Simon, Richard},
  journal={Controlled clinical trials},
  volume={10},
  number={1},
  pages={1--10},
  year={1989},
  publisher={Elsevier}
}

 @Manual{clinfun,
    title = {clinfun: Clinical Trial Design and Data Analysis Functions},
    author = {Venkatraman E. Seshan},
    year = {2015},
    note = {R package version 1.0.11},
    url = {http://CRAN.R-project.org/package=clinfun},
  }

@Manual{dfcrm,
    title = {dfcrm: Dose-finding by the continual reassessment method},
    author = {Ken Cheung},
    year = {2013},
    note = {R package version 0.2-2},
    url = {http://CRAN.R-project.org/package=dfcrm},
  }
  
  @article{rogatko.jco,
  title={Translation of innovative designs into phase I trials},
  author={Rogatko, Andr{\'e} and Schoeneck, David and Jonas, William and Tighiouart, Mourad and Khuri, Fadlo R and Porter, Alan},
  journal={Journal of Clinical Oncology},
  volume={25},
  number={31},
  pages={4982--4986},
  year={2007},
  publisher={American Society of Clinical Oncology}
}

@article{thall.biometrics,
  title={Practical Bayesian guidelines for phase IIB clinical trials},
  author={Thall, Peter F and Simon, Richard},
  journal={Biometrics},
  pages={337--349},
  year={1994},
  publisher={JSTOR}
}

@article{flaherty.nejm,
  title={Inhibition of mutated, activated BRAF in metastatic melanoma},
  author={Flaherty, Keith T and Puzanov, Igor and Kim, Kevin B and Ribas, Antoni and McArthur, Grant A and Sosman, Jeffrey A and O'Dwyer, Peter J and Lee, Richard J and Grippo, Joseph F and Nolop, Keith and others},
  journal={New England Journal of Medicine},
  volume={363},
  number={9},
  pages={809--819},
  year={2010},
  publisher={Mass Medical Soc}
}

@article{chevret.sim,
  title={The continual reassessment method in cancer phase I clinical trials: a simulation study},
  author={Chevret, Sylvie},
  journal={Statistics in medicine},
  volume={12},
  number={12},
  pages={1093--1108},
  year={1993},
  publisher={Wiley Online Library}
}

@article{goodman.sim,
  title={Some practical improvements in the continual reassessment method for phase I studies},
  author={Goodman, Steven N and Zahurak, Marianna L and Piantadosi, Steven},
  journal={Statistics in medicine},
  volume={14},
  number={11},
  pages={1149--1161},
  year={1995},
  publisher={Wiley Online Library}
}

@article{korn.sim,
  title={A comparison of two phase I trial designs},
  author={Korn, Edward L and Midthune, Douglas and Chen, T Timothy and Rubinstein, Lawrence V and Christian, Michaele C and Simon, Richard M},
  journal={Statistics in medicine},
  volume={13},
  number={18},
  pages={1799--1806},
  year={1994},
  publisher={Wiley Online Library}
}

@article{piantadosi.ccp,
  title={Practical implementation of a modified continual reassessment method for dose-finding trials},
  author={Piantadosi, S and Fisher, JD and Grossman, S},
  journal={Cancer chemotherapy and pharmacology},
  volume={41},
  number={6},
  pages={429--436},
  year={1998},
  publisher={Springer}
}

@Article{bcrm,
    title = {{bcrm}: Bayesian Continual Reassessment Method Designs for Phase I Dose-Finding Trials},
    author = {Michael Sweeting and Adrian Mander and Tony Sabin},
    journal = {Journal of Statistical Software},
    year = {2013},
    volume = {54},
    number = {13},
    pages = {1--26},
    url = {http://www.jstatsoft.org/article/view/v054i13},
  }

@article{mandrekar.jto,
  title={Randomized phase {II} trials: time for a new era in clinical trial design},
  author={Mandrekar, Sumithra J and Sargent, Daniel J},
  journal={Journal of Thoracic Oncology},
  volume={5},
  number={7},
  pages={932--934},
  year={2010},
  publisher={Elsevier}
}

@article{lindley.tas,
  title={Inference for a Bernoulli process (a Bayesian view)},
  author={Lindley, Dennis V and Phillips, LD},
  journal={The American Statistician},
  volume={30},
  number={3},
  pages={112--119},
  year={1976},
  publisher={Taylor \& Francis Group}
}

@book{yin2012,
  title={Clinical Trial Design: Bayesian and Frequentist Adaptive Methods},
  author={Yin, Guosheng},
  volume={876},
  year={2012},
  publisher={John Wiley \& Sons}
}

@article{sargent.jbs,
  title={Current issues in oncology drug development, with a focus on Phase II trials},
  author={Sargent, Daniel J and Taylor, Jeremy MG},
  journal={Journal of biopharmaceutical statistics},
  volume={19},
  number={3},
  pages={556--562},
  year={2009},
  publisher={Taylor \& Francis}
}

@article{antman.circulation,
  title={Clinical trials in cardiovascular medicine},
  author={Antman, Elliott M},
  journal={Circulation},
  volume={103},
  number={21},
  pages={e101--e104},
  year={2001},
  publisher={Am Heart Assoc}
}

@article{hauschild.lancet,
  title={Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial},
  author={Hauschild, Axel and Grob, Jean-Jacques and Demidov, Lev V and Jouary, Thomas and Gutzmer, Ralf and Millward, Michael and Rutkowski, Piotr and Blank, Christian U and Miller, Wilson H and Kaempgen, Eckhart and others},
  journal={The Lancet},
  volume={380},
  number={9839},
  pages={358--365},
  year={2012},
  publisher={Elsevier}
}

@article{wu.lancetoncology,
  title={Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial},
  author={Wu, Yi-Long and Zhou, Caicun and Hu, Cheng-Ping and Feng, Jifeng and Lu, Shun and Huang, Yunchao and Li, Wei and Hou, Mei and Shi, Jian Hua and Lee, Kye Young and others},
  journal={The lancet oncology},
  volume={15},
  number={2},
  pages={213--222},
  year={2014},
  publisher={Elsevier}
}

@article{schoenfeld.biometrika,
  title={The asymptotic properties of nonparametric tests for comparing survival distributions},
  author={Schoenfeld, David},
  journal={Biometrika},
  volume={68},
  number={1},
  pages={316--319},
  year={1981},
  publisher={Biometrika Trust}
}

@article{schoenfeld.biometrics,
  title={Sample-size formula for the proportional-hazards regression model},
  author={Schoenfeld, David A},
  journal={Biometrics},
  pages={499--503},
  year={1983},
  publisher={JSTOR}
}

@article{mcelhaney.lancetinfection,
  title={AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial},
  author={McElhaney, Janet E and Beran, Jiri and Devaster, Jeanne-Marie and Esen, Meral and Launay, Odile and Leroux-Roels, Geert and Ruiz-Palacios, Guillermo M and van Essen, Gerrit A and Caplanusi, Adrian and Claeys, Carine and others},
  journal={The Lancet Infectious Diseases},
  volume={13},
  number={6},
  pages={485--496},
  year={2013},
  publisher={Elsevier}
}

@article{besarab.nejm,
  title={The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin},
  author={Besarab, Anatole and Bolton, W Kline and Browne, Jeffrey K and Egrie, Joan C and Nissenson, Allen R and Okamoto, Douglas M and Schwab, Steve J and Goodkin, David A},
  journal={New England Journal of Medicine},
  volume={339},
  number={9},
  pages={584--590},
  year={1998},
  publisher={Mass Medical Soc}
}

@article{nott.annintmed,
  title={Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial},
  author={{Nocturnal Oxygen Therapy Trial Group} and others},
  journal={Ann Intern Med},
  volume={93},
  number={3},
  pages={391--398},
  year={1980}
}

@inproceedings{goodkin.semdial,
  title={The normal hematocrit cardiac trial revisited},
  author={Goodkin, David A},
  booktitle={Seminars in dialysis},
  volume={22},
  number={5},
  pages={495--502},
  year={2009},
  organization={Wiley Online Library}
}

@article{cortazar.lancet,
  title={Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis},
  author={Cortazar, Patricia and Zhang, Lijun and Untch, Michael and Mehta, Keyur and Costantino, Joseph P and Wolmark, Norman and Bonnefoi, Herv{\'e} and Cameron, David and Gianni, Luca and Valagussa, Pinuccia and others},
  journal={The Lancet},
  volume={384},
  number={9938},
  pages={164--172},
  year={2014}
}

@article{fleming.annintmed,
  title={Surrogate end points in clinical trials: are we being misled?},
  author={Fleming, Thomas R and DeMets, David L},
  journal={Annals of internal medicine},
  volume={125},
  number={7},
  pages={605--613},
  year={1996},
  publisher={Am Coll Physicians}
}

@article{buyse.nrco,
  title={Biomarkers and surrogate end points?the challenge of statistical validation},
  author={Buyse, Marc and Sargent, Daniel J and Grothey, Axel and Matheson, Alastair and De Gramont, Aimery},
  journal={Nature reviews Clinical oncology},
  volume={7},
  number={6},
  pages={309--317},
  year={2010},
  publisher={Nature Publishing Group}
}

@article{wei.cct,
  title={Properties of the urn randomization in clinical trials},
  author={Wei, LJ and Lachin, John M},
  journal={Controlled Clinical Trials},
  volume={9},
  number={4},
  pages={345--364},
  year={1988},
  publisher={Elsevier}
}

@article{zelen.jcd,
  title={The randomization and stratification of patients to clinical trials},
  author={Zelen, Marvin},
  journal={Journal of Chronic Diseases},
  volume={27},
  number={7},
  pages={365--375},
  year={1974},
  publisher={Elsevier}
}

@article{bartlett.ped,
  title={Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study},
  author={Bartlett, Robert H and Roloff, Dietrich W and Cornell, Richard G and Andrews, Alice French and Dillon, Peter W and Zwischenberger, Joseph B},
  journal={Pediatrics},
  volume={76},
  number={4},
  pages={479--487},
  year={1985}
}


  @article{smithells.lancet,
title = "POSSIBLE PREVENTION OF NEURAL-TUBE DEFECTS BY PERICONCEPTIONAL VITAMIN SUPPLEMENTATION",
journal = "The Lancet ",
volume = "315",
number = "8164",
pages = "339 - 340",
year = "1980",
note = "Originally published as Volume 1, Issue 8164 ",
author = "R.W. Smithells and S. Sheppard and C.J. Schorah and M.J. Seller and N.C. Nevin and R. Harris and A.P. Read and D.W. Fielding"
}

@article{altman.bmj,
  title={Treatment allocation in controlled trials: why randomise?},
  author={Altman, Douglas G and Bland, J Martin},
  journal={BMJ},
  volume={318},
  number={7192},
  pages={1209--1209},
  year={1999}
  }
  
  @article{hareyama.cancer,
  title={High-dose-rate versus low-dose-rate intracavitary therapy for carcinoma of the uterine cervix},
  author={Hareyama, Masato and Sakata, Koh-ichi and Oouchi, Atushi and Nagakura, Hisayasu and Shido, Mitsuo and Someya, Masanori and Koito, Kazumitsu},
  journal={Cancer},
  volume={94},
  number={1},
  pages={117--124},
  year={2002}
}

@article{chalmers.nejm,
author = { Chalmers ,  Thomas C.  and  Matta ,  Raymond J.  and  Smith ,  Harry   Jr.  and  Kunzler ,  Anne-Marie },
title = {Evidence Favoring the Use of Anticoagulants in the Hospital Phase of Acute Myocardial Infarction},
journal = {New England Journal of Medicine},
volume = {297},
number = {20},
pages = {1091-1096},
year = {1977}
}

@article{rubin.aos,
  title={Bayesian inference for causal effects: The role of randomization},
  author={Rubin, Donald B},
  journal={The Annals of statistics},
  pages={34--58},
  year={1978},
  publisher={JSTOR}
}

@article{rubin.jasa,
  title={Causal inference using potential outcomes},
  author={Rubin, Donald B},
  journal={Journal of the American Statistical Association},
  year={2011},
  publisher={Taylor \& Francis}
}

@article{lachin.cct,
  title={Statistical properties of randomization in clinical trials},
  author={Lachin, John M},
  journal={Controlled Clinical Trials},
  volume={9},
  number={4},
  pages={289--311},
  year={1988},
  publisher={Elsevier}
}

@article{robinson.isr,
  title={Some surprising results about covariate adjustment in logistic regression models},
  author={Robinson, Laurence D and Jewell, Nicholas P},
  journal={International Statistical Review/Revue Internationale de Statistique},
  pages={227--240},
  year={1991},
  publisher={JSTOR}
}

@article{chastang.sim,
  title={A quantitative study of the bias in estimating the treatment effect caused by omitting a balanced covariate in survival models},
  author={Chastang, Claude and Byar, David and Piantadosi, Steven},
  journal={Statistics in Medicine},
  volume={7},
  number={12},
  pages={1243--1255},
  year={1988},
  publisher={Wiley Online Library}
}

@book{rosenberger,
  title={{Randomization in clinical trials: Theory and practice}},
  author={Rosenberger, William F and Lachin, John M},
  year={2004},
  publisher={John Wiley \& Sons},
  address = {New York}
}

@article{pocock.biometrika,
  title={Group sequential methods in the design and analysis of clinical trials},
  author={Pocock, Stuart J},
  journal={Biometrika},
  volume={64},
  number={2},
  pages={191--199},
  year={1977},
  publisher={Biometrika Trust}
}

@article{obrien.biometrics,
  title={A multiple testing procedure for clinical trials},
  author={O'Brien, Peter C and Fleming, Thomas R},
  journal={Biometrics},
  pages={549--556},
  year={1979},
  publisher={JSTOR}
}

@book{jennison,
  title={Group sequential methods with applications to clinical trials},
  author={Jennison, Christopher and Turnbull, Bruce W},
  year={1999},
  publisher={CRC Press}
}

@article{smithells.lancet,
  title={Possible prevention of neural-tube defects by periconceptional vitamin supplementation},
  author={Smithells, RW and Sheppard, S and Stone, DavidH and Fernhaff, PaulM and Elwood, JH},
  journal={The Lancet},
  volume={315},
  number={8169},
  pages={647--648},
  year={1980},
  publisher={Elsevier}
}

@article{ji.jco,
  title={Modified toxicity probability interval design: a safer and more reliable method than the 3+ 3 design for practical phase I trials},
  author={Ji, Yuan and Wang, Sue-Jane},
  journal={Journal of Clinical Oncology},
  volume={31},
  number={14},
  pages={1785--1791},
  year={2013},
  publisher={American Society of Clinical Oncology}
}

@article{yuan.ccr,
  title={Bayesian optimal interval design: a simple and well-performing design for phase I oncology trials},
  author={Yuan, Ying and Hess, Kenneth R and Hilsenbeck, Susan G and Gilbert, Mark R},
  journal={Clinical Cancer Research},
  volume={22},
  number={17},
  pages={4291--4301},
  year={2016},
  publisher={American Association for Cancer Research}
}

@article{thall.ct,
  title={Current issues in dose-finding designs: A response to the US Food and Drug Adminstration’s Oncology Center of Excellence Project Optimus},
  author={Thall, Peter F and Garrett-Mayer, Elizabeth and Wages, Nolan A and Halabi, Susan and Cheung, Ying Kuen},
  journal={Clinical Trials},
  volume={21},
  number={3},
  pages={267--272},
  year={2024},
  publisher={SAGE Publications Sage UK: London, England}
}

@article{shah.nejm,
  title={The drug-dosing conundrum in oncology—when less is more},
  author={Shah, Mirat and Rahman, Atiqur and Theoret, Marc R and Pazdur, Richard},
  journal={New England Journal of Medicine},
  volume={385},
  number={16},
  pages={1445--1447},
  year={2021},
  publisher={Mass Medical Soc}
}

@article{cheung.ct,
  title={Sixteenth Annual University of Pennsylvania conference on statistical issues in clinical trial/optimizing dose-finding across the clinical trials spectrum (morning panel discussion)},
  author={Cheung, Ken and Garrett-Mayer, Elizabeth},
  journal={Clinical Trials},
  pages={17407745251351291},
  year={2025},
  publisher={SAGE Publications Sage UK: London, England}
}

@article{wong.biostatistics,
  title={Estimation of clinical trial success rates and related parameters},
  author={Wong, Chi Heem and Siah, Kien Wei and Lo, Andrew W},
  journal={Biostatistics},
  volume={20},
  number={2},
  pages={273--286},
  year={2019},
  publisher={Oxford University Press}
}

@article{jaki.ejc,
  title={Early phase clinical trials in oncology: Realising the potential of seamless designs},
  author={Jaki, Thomas and Burdon, Abigail and Chen, Xijin and Mozgunov, Pavel and Zheng, Haiyan and Baird, Richard},
  journal={European Journal of Cancer},
  volume={189},
  pages={112916},
  year={2023},
  publisher={Elsevier}
}

@article{boonstra.ct,
  title={A modular framework for early-phase seamless oncology trials},
  author={Boonstra, Philip S and Braun, Thomas M and Chase, Elizabeth C},
  journal={Clinical Trials},
  volume={18},
  number={3},
  pages={303--313},
  year={2021},
  publisher={SAGE Publications Sage UK: London, England}
}

@article{boonstra.plosone,
  title={Targeted randomization dose optimization trials enable fractional dosing of scarce drugs},
  author={Boonstra, Philip S and Tabarrok, Alex and Strohbehn, Garth W},
  journal={Plos one},
  volume={18},
  number={10},
  pages={e0287511},
  year={2023},
  publisher={Public Library of Science San Francisco, CA USA}
}

@article{boonstra.jnci,
  title={A statistical evaluation of dose expansion cohorts in phase I clinical trials},
  author={Boonstra, Philip S and Shen, Jincheng and Taylor, Jeremy MG and Braun, Thomas M and Griffith, Kent A and Daignault, Stephanie and Kalemkerian, Gregory P and Lawrence, Theodore S and Schipper, Matthew J},
  journal={Journal of the National Cancer Institute},
  volume={107},
  number={3},
  pages={dju429},
  year={2015},
  publisher={Oxford University Press US}
}
